VaramirStart free · no cardSign in
DYN as of Nov 2 · 12:16 ET
DYNNasdaqPharmaceutical Preparations

Dyne Therapeutics, Inc. · Brief

Next report

2 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±18.7%
avg realized
±6.4%
Feb 27 '25±16.3%▼−4.50%×0.28
May 8 '25±22.6%▲+20.16%×0.89
Jul 28 '25±13.9%▼−1.18%×0.08
Nov 5 '25±20.9%▼−12.89%×0.62
Jan 12 '26±10.7%▼−1.74%×0.16
Q1 FY26±26.6%▲+3.39%×0.13
May 11 '26±21.6%▲+4.83%×0.22
Q2 FY26±16.7%▲+2.51%×0.15
quarterimplied−30%0+30%realized×
Q2 FY26±16.7%▲+2.51%×0.15
May '26±21.6%▲+4.83%×0.22
Q1 FY26±26.6%▲+3.39%×0.13
Jan '26±10.7%▼−1.74%×0.16
Nov '25±20.9%▼−12.89%×0.62
Jul '25±13.9%▼−1.18%×0.08
2 older reports
May '25±22.6%▲+20.16%×0.89
Feb '25±16.3%▼−4.50%×0.28
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

245managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+3.55%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

4tracked funds holding DYNN-PORT · Aug 31 '26
0.86%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DYN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±19.6% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.